evaluation of prognostic values of tissue plasminogen activator and plasminogen activator inhibitor-1 in crimean-congo hemorrhagic fever patients

نویسندگان

yunus gurbuz infectious diseases and clinical microbiology clinics, diskapi yildirim beyazit training and research hospital, ministry of health, ankara, turkey

baris ozturk infectious diseases and clinical microbiology clinics, ulucanlar training and research hospital, ministry of health, ankara, turkey; infectious diseases and clinical microbiology clinics, ulucanlar training and research hospital, ministry of health, ankara, turkey. tel: +90-5056434048, fax: +90-3123123805

emin ediz tutuncu infectious diseases and clinical microbiology clinics, diskapi yildirim beyazit training and research hospital, ministry of health, ankara, turkey

irfan sencan infectious diseases and clinical microbiology clinics, diskapi yildirim beyazit training and research hospital, ministry of health, ankara, turkey

چکیده

results a total of 46 patients participated in this study. the significant differences between recovering patients and the patients who died, regarding aspartate aminotransferase (ast), creatine phosphokinase (cpk), lactate dehydrogenase (ldh), prothrombin time (pt), activated partial thromboplastin time (aptt), and thrombocyte and fibrinogen levels, were consistent with many clinical studies in the literature. the fatal cases were found to have higher tpa and pai-1 levels in contrast to the patients who completely recovered. objectives in this study we aimed to determine the levels of tissue plasminogen activator (tpa) and plasminogen activator inhibitor-1 (pai-1) as predictors of prognosis in cchf. patients and methods patients who were diagnosed by the polymerase chain reaction (pcr) and igm positivity in the reference laboratory were included in this study. tissue plasminogen activator and pai-1 levels were measured by the enzyme linked immunosorbent assay (elisa) using a commercial kit (human t-pa elisa and human pal-1 elisa; biovendor research and diagnostic products, biovendor-laboratorni medicina a.s., brno, czech republic). background crimean-congo hemorrhagic fever (cchf) is a widespread disease in turkey, and was responsible for many deaths in endemic regions during the last decade. the pathogenesis of the disease is not fully understood yet. conclusions we think that these findings may help the progress of understanding of cchf pathogenesis.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients

BACKGROUND Crimean-Congo hemorrhagic fever (CCHF) is a widespread disease in Turkey, and was responsible for many deaths in endemic regions during the last decade. The pathogenesis of the disease is not fully understood yet. OBJECTIVES In this study we aimed to determine the levels of tissue plasminogen activator (tPA) and Plasminogen activator inhibitor-1 (PAI-1) as predictors of prognosis i...

متن کامل

The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever.

BACKGROUND Crimean-Congo hemorrhagic fever (CCHF) is a potentially fatal disease caused by a tick-borne virus from the Bunyaviridae family. It has recently been reported that soluble urokinase-type plasminogen activator receptor (suPAR), secreted from endothelial cells and the mononuclear phagocyte system, one of the main targets of the CCHF virus, is a potential biomarker for several bacterial...

متن کامل

Serum Level of Plasminogen Activator Inhibitor Type-1 in Addicted Patients ‎with Coronary Artery Disease

Background: Plasminogen activator inhibitor-1 (PAI-1) is a glycoprotein with inhibitory effects on the formation of plasmin from plasminogen by plasminogen activator. Thus, it prevents clot lysis in vessel walls. Several evidences prove the relationship between coronary artery disease and response to fibrinolytic therapy in patients with myocardial infarction with PAI-1 level. Opium addiction i...

متن کامل

Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.

UNLABELLED BACKGROUND NAD PURPOSE: Abnormalities in the fibrinolytic system have been associated with an increased risk for stroke in a few studies. This study was designed to test whether plasma levels of tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and tPA/PAI-1 complex could predict a first-ever stroke. METHODS The study was an incident case-control study ...

متن کامل

Alu DNA Polymorphism of Human Tissue Plasminogen Activator (tPA) Gene in Diabetic Jordanian Patients Patients

Background: Hypercoagulability and hypofibrinolysis are among the symptoms exhibited by diabetic patients. Our study aimed to address the polymorphic nature of Alu DNA fragment in the human tissue plasminogen activator gene within diabetes mellitus (DM) Jordanian patients. Methods: Genomic DNA was isolated from 76 DM patients and 60 non-diabetic Jordanian individuals, and the Alu fragment was a...

متن کامل

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication

To investigate the effects of reactive oxygen species (ROS) on tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) plasma levels, and their possible implications on clinical outcome, we measured tPA and PAI-1 levels in 101 patients with acute paraquat (PQ) intoxication. The control group consisted of patients who ingested non-PQ pesticides during the same period. tP...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
jundishapur journal of microbiology

جلد ۸، شماره ۱۰، صفحات ۰-۰

کلمات کلیدی
[ ' c r i m e a n ' , ' c o n g o h e m o r r h a g i c f e v e r ' , ' t i s s u e p l a s m i n o g e n a c t i v a t o r ' , ' p l a s m i n o g e n a c t i v a t o r i n h i b i t o r ' , 1 ]

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023